TerrAscend (TSNDF) Invested Capital (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Invested Capital of $777000.0 for Q1 2026, down 76.37% year-over-year from $3.3 million in Q1 2025, and down 85.4% quarter-over-quarter from $5.3 million in Q4 2025.
TerrAscend (TSNDF) Invested Capital (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Invested Capital for 6 consecutive years, with $777000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital fell 76.37% year-over-year to $777000.0; the TTM figure through Mar 2026 stood at $17.0 million (down 49.53% YoY), while the FY2025 annual figure was $5.3 million, down 21.28% from the prior year.
- Invested Capital declined to $777000.0 in Q1 2026 per TSNDF's latest filing, from $5.3 million in the prior quarter.
- Across five years, Invested Capital topped out at $124.5 million in Q1 2024 and bottomed at $554000.0 in Q2 2025.
- Historically, Invested Capital has averaged $24.8 million across 5 years, with a median of $7.7 million in 2024.
- Annual changes were most pronounced in 2023 — Invested Capital soared 1550.51% — and 2025, when it sank 97.36%.
- TerrAscend's Invested Capital stood at $5.2 million in 2022, then gained by 24.34% to $6.4 million in 2023, then climbed by 4.89% to $6.8 million in 2024, then retreated by 21.28% to $5.3 million in 2025, then plunged by 85.4% to $777000.0 in 2026.
- Business Quant data shows TSNDF's Invested Capital at $777000.0 in Q1 2026, $5.3 million in Q4 2025, and $10.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 14.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.05 Mn |
| Mar 31, 2026 | 777,000.00 |
| Dec 31, 2025 | 5.32 Mn |
| Sep 30, 2025 | 10.36 Mn |
| Jun 30, 2025 | 554,000.00 |
| Mar 31, 2025 | 3.29 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | 15.95 Mn |
| Mar 31, 2024 | 124.55 Mn |
| Dec 31, 2023 | 6.45 Mn |
| Sep 30, 2023 | 21.83 Mn |
| Jun 30, 2023 | 23.93 Mn |
| Mar 31, 2023 | 51.40 Mn |
| Dec 31, 2022 | 5.18 Mn |
| Sep 30, 2022 | 75.31 Mn |
| Jun 30, 2022 | 58.86 Mn |
| Mar 31, 2022 | 3.11 Mn |
| Dec 31, 2021 | 9.98 Mn |